Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Obesity (Silver Spring). 2015 Apr 10;23(5):950–956. doi: 10.1002/oby.21069

Table 2.

Treatment effect of oxytocin on fasting levels of hormones, triglycerides and glucose

Mean
Baseline Value
Treatment
Effect Estimate
P-value*
Insulin (uU/mL) 7.0±0.9 −1.7±0.8 0.04
Glucose (mg/dL) 84.6±1.2 −0.1±0.5 0.9
HOMA-IR 1.5±0.2 −0.4±0.2 0.04
Triglycerides (mg/dL ) 103.1±7.4 −1.8±1.0 0.07
Oxytocin (pg/mL) 965.0±53.7 −32.5±20.7 0.1
CCK (pg/mL) 72.5±11.0 10.9±3.1 0.002
Leptin (ng/mL) 3.7±0.5 −0.1±0.2 0.5
Active Ghrelin (pg/mL) 92.2±6.1 14.4±12.1 0.2
PYY (pg/mL) 61.9±5.2 0.6±2.5 0.8

Mean±SEM

Bold typeface indicates p-value <0.05

*

p-value, overall repeated measures